Form D · Biotechnology
Dvant Pharma, Inc.
Superior Township, MI · CIK 0002158986
Offering snapshot reported Oct 13, 2026 · SEC filing
- Reported sold
- $1.23M Offering amount: $3.09M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 29, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 13, 2026 | Initial | $1,230,400 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-601004
Source: Form D, filed Oct 13, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jim Adox | Director |
| Vincent Alessi | Director |
| Andrew Joseph Kocab | Director, Executive |
| Mukesh Nyati | Director, Executive |
| Frank Perabo | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3646 Northbrook Drive
Superior Township, MI, 48198
Phone: 734-249-9234
Superior Township, MI, 48198
Phone: 734-249-9234